A Transient Transfection-based Cell Adhesion Assay with 293T Cells

Cell adhesion is a key process in cancer progression and metastasis. Researchers have long used in vitro assays to study how cancer cells interact with specific proteins. These assays typically require purified proteins immobilized on solid surfaces. However, purifying some proteins can be challenging, especially when their native structure is hard to maintain. This limitation restricts the range of proteins that can be studied using traditional methods. The need for a more accessible and reliable approach has driven the development of alternative techniques. One such approach involves using transfected cell lines to express target proteins directly. This method allows for the study of cell adhesion without the need for protein purification. By expressing the protein of interest in a cell monolayer, researchers can assess adhesion in a more biologically relevant context. This innovation addresses a critical gap in the field of cell adhesion research.

The goal of this study was to develop a transient transfection-based cell adhesion assay using 293T cells. This method aims to simplify the study of selective cell adhesion to specific proteins. Traditional methods rely on purified proteins, which can be difficult to obtain and maintain in their native form. The new protocol uses 293T cells to express the target protein directly. This eliminates the need for protein purification and allows for the study of proteins that are otherwise hard to work with. The assay uses a mammalian expression plasmid containing mSiglec1 cDNA or an empty plasmid as a control. The transfected cells form a monolayer that serves as a surface for adhesion experiments. By comparing the adhesion of cancer cells to these monolayers, researchers can assess the selectivity of cell adhesion. This approach provides a more practical and biologically relevant method for studying cell adhesion.

The method involves transfecting 293T cells with a plasmid containing mSiglec1 cDNA or an empty plasmid. These cells are then cultured to form a monolayer. The monolayers are used as a surface for adhesion experiments. GFP-expressing B16F10 cancer cells are introduced to the monolayers. The number of adhering cancer cells is quantified to assess adhesion. This approach avoids the need to purify the target protein. The use of transfected cells maintains the native structure of the protein. The assay is performed in a controlled cell culture environment. This method allows for the study of cell adhesion in a biologically relevant context.

The assay successfully demonstrated the selective adhesion of B16F10 cells to Siglec1-expressing 293T monolayers. The number of adhering cancer cells was significantly higher on Siglec1-expressing monolayers compared to mock-transfected controls. This indicates that the method can effectively measure selective cell adhesion. The use of transfected cells eliminates the need for protein purification. The native structure of the protein is preserved in the monolayer. The assay can be applied to proteins that are difficult to purify. The method provides a reliable and reproducible way to study cell adhesion. These findings support the use of this approach in cell adhesion research.

The transient transfection-based cell adhesion assay offers a practical alternative to traditional methods. It eliminates the need to purify and immobilize proteins on solid surfaces. The method uses 293T cells to express the target protein directly. This approach maintains the native structure of the protein. The assay can be used to study proteins that are difficult to purify. The results suggest that the method is effective for measuring selective cell adhesion. The use of transfected cells provides a biologically relevant context. This approach supports further research into cell adhesion mechanisms.